Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M7.7Revenue $M1.8Net Margin (%)-841.1Altman Z-Score-24.9
Enterprise Value $M-4.9EPS $-1.0Operating Margin %-870.1Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.2Pre-tax Margin (%)-841.1Higher ROA y-yN
Price/Book0.810-y EBITDA Growth Rate %-9.7Quick Ratio2.2Cash flow > EarningsN
Price/Sales2.55-y EBITDA Growth Rate %-46.6Current Ratio2.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-74.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-105.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M24.0ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with DCTH

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DCTHGeorge Soros 2011-03-31 Sold Out $98.88 - $183.04
($137.87)
$ 0.32-100%Sold Out0
DCTHGeorge Soros 2010-12-31 Add$115.2 - $180.32
($151.45)
$ 0.32-100%Add 7.14%1,312
DCTHGeorge Soros 2010-09-30 Buy $88.48 - $139.04
($113.04)
$ 0.32-100%New holding1,225
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DCTH is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


DCTH: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Taglietti MarcoDirector 2015-07-28Buy200,000$0.53-39.62view
STOLL ROGER G PHDDirector 2015-07-27Buy20,000$0.54-40.74view
Philips Laura ADirector 2015-07-23Buy162,653$0.5-36view
Rueckert William DodgeDirector 2015-07-22Buy20,000$0.48-33.33view
APPLING WILLIAM MEVP, R&D and Global Operations 2013-06-25Sell0$0-33.33view
APPLING WILLIAM MEVP, R&D and Global Operations 2013-06-25Sell0$0-33.33view
LEUNG GABRIELDirector 2012-06-15Buy469$25.12-98.73view
Koplewicz Harold SDirector 2012-06-01Buy4,167$23.84-98.66view
Purpura JohnEVP Reg. Affairs/Quality Assur 2012-06-01Buy313$23.84-98.66view
HOBBS EAMONN PPresident and CEO 2012-06-01Buy438$24.32-98.68view

Quarterly/Annual Reports about DCTH:

News about DCTH:

Articles On GuruFocus.com
Five NCAV Companies for Value Investors – August 2015 Aug 04 2015 
Weekly CFO Buys Highlight: BWEN, EMC, INO, DCTH, ACCO Jun 11 2012 
Delcath Systems Inc. Reports Operating Results (10-Q) Oct 23 2009 

More From Other Websites
Delcath Announces First CHEMOSAT® Procedures In Turkey Apr 08 2016
Delcath Announces First CHEMOSAT® Procedures In Turkey Apr 08 2016
DELCATH SYSTEMS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Apr 07 2016
DELCATH SYSTEMS, INC. Financials Mar 24 2016
DELCATH SYSTEMS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 23 2016
Delcath Systems, Inc. :DCTH-US: Earnings Analysis: Q4, 2015 By the Numbers Mar 23 2016
Delcath Systems, Inc. :DCTH-US: Earnings Analysis: 2015 By the Numbers Mar 22 2016
Delcath Announces 2015 Fourth Quarter and Full Year Financial Results Mar 21 2016
Delcath Announces 2015 Fourth Quarter and Full Year Financial Results Mar 21 2016
DELCATH SYSTEMS, INC. Files SEC form 10-K, Annual Report Mar 18 2016
Delcath to Present at the 28th Annual ROTH Conference Mar 07 2016
Delcath announces Engagement of Lars E. Birgerson, M.D., Ph. D as global medical consultant Feb 11 2016
DELCATH SYSTEMS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Feb 10 2016
Delcath Announces Beginning Of Patient Enrollment In Phase 3 Focus Trial Feb 10 2016
Delcath Systems to Present at Upcoming Investor Conferences Feb 04 2016
DELCATH SYSTEMS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 22 2016
Delcath Announces Initiation Of Phase 3 Trial Of Melphalan/HDS System For Treatment Of Hepatic... Jan 20 2016
Delcath Announces Initiation Of Phase 3 Trial Of Melphalan/HDS System For Treatment Of Hepatic... Jan 20 2016
MicroCap Review Magazine Winter/Spring 2016 Issue Now Available Jan 19 2016
Delcath Announces Special Protocol Assessment Agreement With FDA For New Phase 3 Trial In Hepatic... Jan 19 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)